A real-world study of TACE combined with regorafenib as a second-line treatment for advanced hepatocellular carcinoma-MedSci.cn

A real-world study of TACE combined with regorafenib as a second-line treatment for advanced hepatocellular carcinoma

Liu, SX; Gao, S; Guo, JH; Kou, FX; Zhang, X; Liu, BJ; Feng, AW; Wang, XD; Chen, H; Zhu, X

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务